Thomas J. Matthews

Overview

Best Publications

• Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

  Carl T. Wild;Diane C. Shugars;Teresa K. Greenwell;Charlene B. McDanal

  1454
  Citations

• Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

  Thomas J. Palker;Michael E. Clark;Alphonse J. Langlois;Thomas J. Matthews

  701
  Citations

• Island biogeography: Taking the long view of nature’s laboratories

  Robert J. Whittaker;Robert J. Whittaker;José María Fernández-Palacios;Thomas J. Matthews;Thomas J. Matthews;Michael K. Borregaard

  609
  Citations

• Changing Bee and Hoverfly Pollinator Assemblages along an Urban-Rural Gradient

  Adam J. Bates;Jon P. Sadler;Alison J. Fairbrass;Steven J. Falk

  464
  Citations

• Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus.

  John J. Dwyer;Karen L. Wilson;Donna K. Davison;Stephanie A. Freel

  339
  Citations

• Immune Responses to Human Immunodeficiency Virus (HIV) Type 1 Induced by Canarypox Expressing HIV-1MN gp120, HIV-1SF2 Recombinant gp120, or Both Vaccines in Seronegative Adults

  Mary Lou Clements-Mann;Kent Weinhold;Thomas J. Matthews;Barney S. Graham

  286
  Citations

• A roadmap for island biology: 50 fundamental questions after 50 years of The Theory of Island Biogeography

  Jairo Patiño;Jairo Patiño;Robert J. Whittaker;Robert J. Whittaker;Paulo A.V. Borges;José María Fernández-Palacios

  234
  Citations

• Augmentation of Human Immunodeficiency Virus Type 1 Neutralizing Antibody by Priming with gp160 Recombinant Vaccinia and Boosting with gp160 in Vaccinia-Naive Adults

  Barney S. Graham;Thomas J. Matthews;Robert B. Belshe;Mary Lou Clements

  229
  Citations

• Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates.

  Prakash R Sista;Tom Melby;Donna Davison;Lei Jin

  215
  Citations

• On the form of species–area relationships in habitat islands and true islands

  Thomas J. Matthews;Thomas J. Matthews;François Guilhaumon;François Guilhaumon;Kostas A. Triantis;Kostas A. Triantis;Michael K. Borregaard

  186
  Citations

• REVIEW: On the species abundance distribution in applied ecology and biodiversity management

  Thomas J. Matthews;Thomas J. Matthews;Robert J. Whittaker;Robert J. Whittaker

  183
  Citations

• Envelope glycoproteins from biologically diverse isolates of immunodeficiency viruses have widely different affinities for CD4.

  Mona Ivey-Hoyle;Jeffrey S. Culp;Margery A. Chaikin;Brian D. Hellmig

  180
  Citations

• Habitat fragmentation and the species–area relationship: a focus on total species richness obscures the impact of habitat loss on habitat specialists

  Thomas J. Matthews;Thomas J. Matthews;H. Eden Cottee-Jones;Robert J. Whittaker;Robert J. Whittaker

  177
  Citations

• A Prime-Boost Approach to HIV Preventive Vaccine Using a Recombinant Canarypox Virus Expressing Glycoprotein 160 (MN) followed by a Recombinant Glycoprotein 160 (MN/LAI)

  Gilles Pialoux;Jean-Louis Excler;Yves Rivière;Gustavo Gonzalez-Canali

  173
  Citations

• Oceanic island biogeography through the lens of the general dynamic model: assessment and prospect.

  Michael K. Borregaard;Michael K. Borregaard;Isabel R. Amorim;Paulo A. V. Borges;Juliano S. Cabral

  156
  Citations

• Habitat Composition and Connectivity Predicts Bat Presence and Activity at Foraging Sites in a Large UK Conurbation

  James D. Hale;Alison J. Fairbrass;Tom J. Matthews;Jon P. Sadler

  149
  Citations

• Neutral theory and the species abundance distribution: recent developments and prospects for unifying niche and neutral perspectives.

  Thomas J. Matthews;Thomas J. Matthews;Robert J. Whittaker;Robert J. Whittaker

  142
  Citations

• Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain.

  Lucinda A. Ivanoff;David J. Looney;Charlene McDANAL;Jane F. Morris

  138
  Citations

• Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors

  Larry M. Cummins;Kent J. Weinhold;Thomas J. Matthews;Alphonse J. Langlois

  134
  Citations

• Safety and Immunogenicity of a Fully Glycosylated Recombinant gp160 Human Immunodeficiency Virus Type 1 Vaccine in Subjects at Low Risk of Infection

  Robert B. Belshe;Mary Lou Clements;Raphael Dolin;Barney S. Graham

  130
  Citations